7Miller JW, Schmidt-Erfuth U, Sickenberg M, et al.Photodynamic therapy for choroidal neovascularization caused by age-related macular degeneration:resuh of a single treatment in a phase 1 and 2 study. Arch Ophthalmol , 1999, 117: 1161-1173.
8Treatment of age-related macular degeneration with photodynamic therapyAP)study group. Verteporfin therapy for subfoveal choroidal neovascu-larization in age-related macular degeneration.Three-year results of an open-label extension of 2 randomized clinical trials. TAP Report No.5. Arch Ophthalmol, 2002, 120: 1307-1314.
7Fukus AM. Classi ficat ion and t reatmen t of diab et ic ret in- opath-y[J]. Diabetic Res CI in Pract, 1994,24 : 171-176.
8Sander B, Larsen M, Moldow B, et al. Diabetic edema: Passive andaetive transport of fluorescein through the blood-retina bar- rier[J]. Invest Ophthalmol Vis Sci,2001,42(2):433-438.
9Blumenkranz MS. Optimal current and future treatments for diabetic macular edema[J]. Eye, 2010,24 (3) : 428-434.
10Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraoeular pressure[J]. Opthalmic Surg Laser Imaging, 2003,34: 390.
